Testing effectiveness (Phase 2)Not Yet RecruitingNCT07513324
What this trial is testing
Risk-adapted Therapy in HPV-positive Oropharyngeal Cancer Using Circulating Tumor (ct) HPV DNA Profiling (ReACT 2.0)
Who this might be right for
HPV-positive Oropharyngeal Squamous Cell CarcinomaOropharyngeal Squamous Cell Carcinoma
Dana-Farber Cancer Institute 116